Conferences

IDMC 15 MEETINg, 26-30 MAY, 2026, SAGUENAY, CANADA

 

ENTRY-DM was strongly represented at IDMC-15 (International Myotonic Dystrophy Consortium Meeting). For more information about ENTRY-DM contributions, please click on the links below: 

Poster by DC8 Mireia Gromaz. Splicing modulation of DMPK EXON 15 as a therapeutic approach for Myotonic Dystrophy Type 1 

https://zenodo.org/records/20717398 

Poster by DC5 Sofia Gaspari. Focusing on foci: Expansion Microscopy for high-resolution characterization of repeat RNA-protein aggregates in DM

https://zenodo.org/records/20717534 

Poster by DC3 Timothée Caboche. A Magnetic Actuator-Based Platform for Functional Assessment of 3D Human Skeletal Muscle Bioengineered Tissues in Myotonic Dystrophy

https://zenodo.org/records/20717652 

Poster by DC9 Yasmine Ferchichi. Enhancing Antisense Oligonucleotide Activity in Myotonic Dystrophy Type 1 by Genetic and Chemical Modulation

https://zenodo.org/records/20717767 

Poster by DCs 6 and 9 Angela Natividad i Mateu and Yasmine Ferchichi. Therapeutic Innovation, Clinical Trial Acceleration, and Lifestyle Interventions in Myotonic Dystrophy Type 1: A Systematic Review

https://zenodo.org/records/20717902 

Poster by DC14 Maria Carolina F. A. OLIVEIRA. Cognitive and social decision-making skills in adult-onset Myotonic Dystrophy type 1 (DM1)

https://zenodo.org/records/20555232 

Poster by DC13 Malin Larsen. Approaching Liquid Biopsy– A Comparative Overview of Current Biomarker Development in Myotonic Dystrophies  

https://zenodo.org/records/20703731 

Poster by DC12 Panagiotis Strevinas. Circulating Biomarkers of Brain Dysfunction in Myotonic Dystrophy type 1 (DM1)

https://zenodo.org/records/20718760 

Poster by DC7 Anton Simoes. Patient-derived iPSC models suggest astrocytic involvement in DM1 neuropathology

https://zenodo.org/records/20728749 

EURO DM CRN  ANNUAL MEETING, MArch 20-21, 2026 COMO, ITALY

 

Coordinator Mario Gomes-Pereira participated in the recent meeting of the European DM Clinical Research Network annual meeting. This meeting provided an excellent opportunity to discuss pre-clinical data from mouse models and how these findings are shaping our understanding of CNS involvement in myotonic dystrophy. Importantly, these discussions are helping to define robust biomarkers that will be critical for pre-clinical development, disease monitoring in patients and patient stratification in ongoing and future clinical trials. During the event, he present edthe work of the ENTRY-DM MSCA Doctoral Network

For more information about the conference: https://euro-dmcrn.org